Growth Metrics

Exagen (XGN) Income from Continuing Operations (2018 - 2026)

Exagen filings provide 9 years of Income from Continuing Operations readings, the most recent being 3967000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 5.73% to 3967000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 20166000.0, a 30.04% decrease, with the full-year FY2025 number at 19951000.0, down 31.99% from a year prior.
  • Income from Continuing Operations hit 3967000.0 in Q1 2026 for Exagen, up from 4673000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 2966000.0 in Q2 2024 to a low of 15117000.0 in Q4 2022.
  • Median Income from Continuing Operations over the past 5 years was 5028000.0 (2024), compared with a mean of 6540176.47.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 128.86% in 2022 and later skyrocketed 65.83% in 2023.
  • Exagen's Income from Continuing Operations stood at 15117000.0 in 2022, then skyrocketed by 63.35% to 5540000.0 in 2023, then soared by 32.11% to 3761000.0 in 2024, then fell by 24.25% to 4673000.0 in 2025, then increased by 15.11% to 3967000.0 in 2026.
  • The last three reported values for Income from Continuing Operations were 3967000.0 (Q1 2026), 4673000.0 (Q4 2025), and 7087000.0 (Q3 2025) per Business Quant data.